Company: GVH
Filing Date: 2025-06-10
Form Type: F-1/A
Source: 0001213900-25-052766
Chunk: 45

Company: Globavend Holdings Ltd
Filing Date: 2025-06-10
Form: F-1/A
Chunk 45
---
 Nasdaq Stock Market has broad discretionary authority to terminate the listing of securities, subject to a
timely-requested hearing, if it determines that continued listing is not in the public interest, even if the issuer is in compliance
with The Nasdaq Stock Market’s enumerated listing criteria. The Series A Warrants and Series B Warrants contain
exercise price reset provisions that may result in a downward adjustment to the exercise price, subject to a floor price. As a
result of such features, the price of our Ordinary Shares issuable upon exercise of the Series A Warrants and Series B
warrants may be substantially below the then existing market price. Further, if the holders of the Series B Warrants elect the
“zero exercise price” option, the maximum number of Ordinary Shares issuable upon exercise of the Series B Warrants
will equal to the product of (a) the number of shares that would be issuable upon exercise of the Series B Warrant in
accordance with the terms of such warrant if such exercise were by means of a cash exercise rather than a cashless exercise and
(b) the quotient obtained by dividing (i) the exercise price minus the Low Price by (ii) 50% of the Low Price,
resulting in a maximum of 242,647,065 Ordinary Shares issuable upon the exercise of the Series B Warrants (assuming the
exercise price is reduced to the Floor Price). If The Nasdaq Stock Market determines the terms of this offering raise public
interest concerns due to the dilutive nature of the transaction, or any other reason, The Nasdaq Stock Market may issue a
determination letter to delist our Ordinary Shares pursuant to its discretionary authority under Listing Rule 5101. In that
event, even if we were to timely request a hearing with respect to The Nasdaq Stock Market’s determination to delist our
Ordinary Shares, The Nasdaq Stock Market may still impose an immediate halt on the trading of our Ordinary Shares pursuant to Nasdaq
Listing Rule 4120(a)(5) pending the outcome of such hearing. If trading in our Ordinary Shares were to be halted or if The
Nasdaq Stock Market were to determine to delist our Ordinary Shares, investors could lose all or part of their investment and our
ability to raise additional capital through the public or private sale of equity securities would be adversely affected.

We are aware of public
disclosures by other Nasdaq-listed companies disclosing that such companies received notification letters from Nasdaq indicating that